Globus Medical Inc (GMED)

$58.60 -0.22 (-0.37%)
Market Cap 7.88B
Revenue (ttm) 2.52B
Net Income (ttm) 102.98M
EPS (ttm) N/A
PE Ratio 18.92
Forward PE 18.42
Profit Margin 4.09%
Debt to Equity Ratio 0.00
Volume 1,461,710
Avg Vol 1,478,636
Day's Range N/A - N/A
Shares Out 135.38M
Stochastic %K 64%
Beta 1.20
Analysts Strong Sell
Price Target $87.82

Company Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 930 1800
Address:
2560 General Armistead Avenue, Audubon, United States
OptionRunners
OptionRunners Jun. 26 at 6:49 PM
$GMED Buyer of the August 15th $57.50 calls (ITM) 500 times for $3.90-$4.00
0 · Reply
A1FinancialCEOMark
A1FinancialCEOMark Jun. 24 at 1:09 PM
$MDT $ACON The Aclarion Buy Out talk we made a video on, well... is now officially ON. We chose MDT as our pick of the 11 suitors, and NOW here's why we were RIGHT-- Just announced today: Medtronic, Aclarion's CEO Brent Ness, formerly in Medtronic management, to present, & meet-- with $GMED, $OFIX, & $ATEC in CABO tomorrow: Read the full story why top Analysts give Aclarion a $481 pt: https://www.a1loansusa.com/aclarion-at-spine-conference
1 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 4:16 AM
$GMED Globus Medical just posted record cash flow and is debt-free. With robotics, AI, and a $2.9B revenue target, this company is flying under the radar.https://biotechhealthx.com/biotech-news/wall-street-is-sleeping-on-globus-medical-gmed-heres-why-you-shouldnt/
0 · Reply
JarvisFlow
JarvisFlow Jun. 4 at 12:30 PM
Barclays has updated their rating for Globus Medical ( $GMED ) to Overweight with a price target of 100.
0 · Reply
Diverstj981
Diverstj981 Jun. 2 at 5:46 PM
$GMED Officially redesignated
0 · Reply
wahoowa96
wahoowa96 May. 30 at 7:46 AM
$GMED "While not as large as Intuitive or as diversified as Stryker or Medtronic, Globus is starting to dominate the spine/musculoskeletal niche, and the coming merger should only reinforce this trend. Considering its lower valuation ratio, this might be a good pick for value investors looking for a cheaper stock with still a high-quality profile and strong growth." https://www.securities.io/top-5-robotic-surgery-stock/
0 · Reply
JarvisFlow
JarvisFlow May. 27 at 1:13 PM
JMP Securities has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Market Perform.
0 · Reply
JarvisFlow
JarvisFlow May. 27 at 12:00 PM
BTIG has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Neutral.
0 · Reply
OpenOutcrier
OpenOutcrier May. 16 at 12:22 PM
$GMED (+2.7% pre) Globus Medical Announces Massive $500M Share Repurchase: Management Signals Stock Undervalued https://ooc.bz/l/65081
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 15 at 8:46 PM
$GMED announces a $500M buyback, claiming shares are undervalued after a 17% post-earnings drop. CFO Pfeil cites confidence in 'intrinsic value,' but with cash reserves down 41% QoQ to $461M, this looks more like a life raft than a growth signal. Execution risk remains high with 1,240 days of inventory. https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/gmed-20250515x8k.htm
0 · Reply
Latest News on GMED
Globus Medical Announces $500 Million Share Repurchase Program

May 15, 2025, 4:30 PM EDT - 6 weeks ago

Globus Medical Announces $500 Million Share Repurchase Program

Medical, Inc. Company Investigated by the Portnoy Law Firm

May 13, 2025, 6:28 PM EDT - 6 weeks ago

Medical, Inc. Company Investigated by the Portnoy Law Firm

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:32 PM EDT - 7 weeks ago

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

Globus Medical Reports First Quarter 2025 Results

May 8, 2025, 4:15 PM EDT - 7 weeks ago

Globus Medical Reports First Quarter 2025 Results

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Apr 17, 2025, 4:30 PM EDT - 2 months ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Globus Medical completes acquisition of Nevro Corp.

Apr 3, 2025, 8:31 AM EDT - 3 months ago

Globus Medical completes acquisition of Nevro Corp.

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

Mar 21, 2025, 11:30 AM EDT - 3 months ago

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

NVRO

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Mar 11, 2025, 4:40 PM EDT - 3 months ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Mar 6, 2025, 4:40 PM EST - 4 months ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Mar 5, 2025, 7:01 PM EST - 4 months ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Mar 4, 2025, 4:15 PM EST - 4 months ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

NVRO

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:54 PM EST - 4 months ago

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:15 PM EST - 4 months ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Feb 6, 2025, 9:30 AM EST - 5 months ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Top 2 Health Care Stocks That May Crash In February

Feb 5, 2025, 6:57 AM EST - 5 months ago

Top 2 Health Care Stocks That May Crash In February

OFIX

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jan 30, 2025, 4:35 PM EST - 5 months ago

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Jan 8, 2025, 4:30 PM EST - 6 months ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Jan 8, 2025, 12:10 PM EST - 6 months ago

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Four hidden gems in the stock market from a five-star fund manager

Dec 16, 2024, 1:32 PM EST - 6 months ago

Four hidden gems in the stock market from a five-star fund manager

CARG PGNY TXRH

Globus Medical Launches ExcelsiusHub™ Navigation System

Nov 22, 2024, 4:30 PM EST - 7 months ago

Globus Medical Launches ExcelsiusHub™ Navigation System

Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 8:12 PM EST - 8 months ago

Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript

Globus Medical Reports Third Quarter 2024 Results

Nov 5, 2024, 4:15 PM EST - 8 months ago

Globus Medical Reports Third Quarter 2024 Results

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud

Nov 3, 2024, 11:00 AM EST - 8 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 30, 2024, 11:00 AM EDT - 8 months ago

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 11:00 AM EDT - 8 months ago

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Investors To Join An Inquiry Into Globus Medical Inc For Possible Securities Fraud

Oct 21, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Globus Medical Inc For Possible Securities Fraud

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Globus Medical Inc For Possible Securities Fraud

Oct 19, 2024, 11:00 AM EDT - 8 months ago

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Globus Medical Inc For Possible Securities Fraud

OptionRunners
OptionRunners Jun. 26 at 6:49 PM
$GMED Buyer of the August 15th $57.50 calls (ITM) 500 times for $3.90-$4.00
0 · Reply
A1FinancialCEOMark
A1FinancialCEOMark Jun. 24 at 1:09 PM
$MDT $ACON The Aclarion Buy Out talk we made a video on, well... is now officially ON. We chose MDT as our pick of the 11 suitors, and NOW here's why we were RIGHT-- Just announced today: Medtronic, Aclarion's CEO Brent Ness, formerly in Medtronic management, to present, & meet-- with $GMED, $OFIX, & $ATEC in CABO tomorrow: Read the full story why top Analysts give Aclarion a $481 pt: https://www.a1loansusa.com/aclarion-at-spine-conference
1 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 4:16 AM
$GMED Globus Medical just posted record cash flow and is debt-free. With robotics, AI, and a $2.9B revenue target, this company is flying under the radar.https://biotechhealthx.com/biotech-news/wall-street-is-sleeping-on-globus-medical-gmed-heres-why-you-shouldnt/
0 · Reply
JarvisFlow
JarvisFlow Jun. 4 at 12:30 PM
Barclays has updated their rating for Globus Medical ( $GMED ) to Overweight with a price target of 100.
0 · Reply
Diverstj981
Diverstj981 Jun. 2 at 5:46 PM
$GMED Officially redesignated
0 · Reply
wahoowa96
wahoowa96 May. 30 at 7:46 AM
$GMED "While not as large as Intuitive or as diversified as Stryker or Medtronic, Globus is starting to dominate the spine/musculoskeletal niche, and the coming merger should only reinforce this trend. Considering its lower valuation ratio, this might be a good pick for value investors looking for a cheaper stock with still a high-quality profile and strong growth." https://www.securities.io/top-5-robotic-surgery-stock/
0 · Reply
JarvisFlow
JarvisFlow May. 27 at 1:13 PM
JMP Securities has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Market Perform.
0 · Reply
JarvisFlow
JarvisFlow May. 27 at 12:00 PM
BTIG has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Neutral.
0 · Reply
OpenOutcrier
OpenOutcrier May. 16 at 12:22 PM
$GMED (+2.7% pre) Globus Medical Announces Massive $500M Share Repurchase: Management Signals Stock Undervalued https://ooc.bz/l/65081
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 15 at 8:46 PM
$GMED announces a $500M buyback, claiming shares are undervalued after a 17% post-earnings drop. CFO Pfeil cites confidence in 'intrinsic value,' but with cash reserves down 41% QoQ to $461M, this looks more like a life raft than a growth signal. Execution risk remains high with 1,240 days of inventory. https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/gmed-20250515x8k.htm
0 · Reply
DonCorleone77
DonCorleone77 May. 15 at 8:34 PM
$GMED Globus Medical announces $500M share repurchase program Globus Medical announced that its board of directors has authorized a share repurchase program of up to $500M of the company's outstanding common stock.
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 14 at 4:09 PM
$GMED probably needs catalysts but the way it’s holding tightly in this channel is a good sign. Still holding sept 55s
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 12 at 6:34 PM
$GMED trading at nearly 1 times price to book, debt free, 5x revenue, raised free cash flow. Love a good sleeper trade that is not crowded
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 12 at 6:15 PM
$GMED added June 55/60 Sept 54/60 calls Risky with the low volume on this one but if this holds should prop back to mid 60s still about 10-15 percent left on the bone here after an overreaction on ER , became debt free and raised guidance. Not worried
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 12 at 5:44 PM
$GMED formed support off an unnecessary selloff, should see 65 shortly if not back to pre earnings price at 70
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 12 at 5:38 PM
$GMED June calls 55/60
0 · Reply
ZacksResearch
ZacksResearch May. 12 at 11:29 AM
$GMED's first-quarter 2025 weak performance reflects soft Enabling Technology deal closures. Read more: https://www.zacks.com/stock/news/2466576/gmed-q1-earnings-revenues-miss-25-eps-view-down-stock-falls?cid=sm-stocktwits-2-2466576-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2466576_TEASER
0 · Reply
Titan202
Titan202 May. 11 at 9:11 AM
$GMED The average price target for Globus Medical is 98.08. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $115.00 ,the lowest forecast is $80.00. The average price target represents 35.36% Increase from the current price of $72.46.
2 · Reply
Fib7867
Fib7867 May. 10 at 10:51 PM
#myGMEDanalysis $GMED
0 · Reply
Titan202
Titan202 May. 10 at 6:05 AM
$GMED https://www.tipranks.com/stocks/gmed/forecast
0 · Reply
Puddlepiratetrading
Puddlepiratetrading May. 9 at 8:59 PM
$GMED had the most inconspicuous halt down today. Daily volume was good though
0 · Reply
traderjoe90
traderjoe90 May. 9 at 7:41 PM
$GMED playa layin wood in Sep 55 calls. $1.6M. Could be a hedge on a larger short. Neverless, always interesting to see large BTO trades late in the market on a Friday.
0 · Reply